Lenvatinib for effectively treating antiangiogenic drug-resistant nasopharyngeal carcinoma.
Sun Q, Wang Y, Ji H, Sun X, Xie S, Chen L, Li S, Zeng W, Chen R, Tang Q, Zuo J, Hou L, Hosaka K, Lu Y, Liu Y, Ye Y, Yang Y.
Sun Q, et al. Among authors: wang y.
Cell Death Dis. 2022 Aug 19;13(8):724. doi: 10.1038/s41419-022-05171-3.
Cell Death Dis. 2022.
PMID: 35985991
Free PMC article.